Armstrong Advisory Group’s Biogen BIIB Stock Holding History

Armstrong Advisory Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$95.7K	Buy	+443	New	+$84.7K	0.01%	352
2026 Q1	–	Sell	-356	Closed	-$62.7K	–	967
2025 Q4	$62.7K	Hold	356	–	–	﹤0.01%	372
2025 Q3	$49.9K	Hold	356	–	–	﹤0.01%	397
2025 Q2	$44.7K	Hold	356	–	–	﹤0.01%	396
2025 Q1	$54.4K	Hold	356	–	–	﹤0.01%	365
2024 Q4	$54.4K	Hold	356	–	–	﹤0.01%	365
2024 Q3	$69K	Hold	356	–	–	0.01%	324
2024 Q2	$82.5K	Hold	356	–	–	0.01%	292
2024 Q1	$92.1K	Hold	356	–	–	0.01%	265
2023 Q4	$92.1K	Hold	356	–	–	0.01%	265
2023 Q3	$91.5K	Hold	356	–	–	0.01%	251
2023 Q2	$101K	Hold	356	–	–	0.01%	234
2023 Q1	$99K	Hold	356	–	–	0.01%	239
2022 Q4	$98.6K	Buy	+356	New	+$101K	0.01%	239

Other funds holding BIIB

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

CIM

Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return

GIC

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Armstrong Advisory Group's BIIB Position: Q2 2026 in Review

Armstrong Advisory Group opened a new position in Biogen (BIIB) in Q2 2026: 443 shares worth $95.7K. The stake represents 0.01% of the portfolio and ranks #352 among its holdings. This is a return to the name: Armstrong Advisory Group previously reported a position in BIIB as recently as Q4 2025.

Armstrong Advisory Group first reported a position in BIIB in Q4 2022 and has held it in 14 quarters since. The position peaked at $101K in Q2 2023. 164 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Armstrong Advisory Group held 443 shares of Biogen worth $95.7K as of Q2 2026.
Biogen was a new Armstrong Advisory Group position in Q2 2026.
Biogen made up 0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #352 holding.
Armstrong Advisory Group first reported a position in Biogen in Q4 2022 and has held it in 14 quarters since.
Armstrong Advisory Group's Biogen position peaked at $101K in Q2 2023.
164 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.